Three-year follow-up of an alectinib phase I/II study in ALK-positive non–small-cell lung cancer: AF-001JP

Tomohide Tamura, Katsuyuki Kiura, Takashi Seto, Kazuhiko Nakagawa, Makoto Maemondo, Akira Inoue, Toyoaki Hida, Hiroshige Yoshioka, Masao Harada, Yuichiro Ohe, Naoyuki Nogami, Haruyasu Murakami, Hiroshi Kuriki, Tadashi Shimada, Tomohiro Tanaka, Kengo Takeuchi, Makoto Nishio

Research output: Contribution to journalArticlepeer-review

56 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Three-year follow-up of an alectinib phase I/II study in ALK-positive non–small-cell lung cancer: AF-001JP'. Together they form a unique fingerprint.

Medicine and Dentistry

Nursing and Health Professions

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology

Neuroscience